Back
Rogers Corp. 10K Form
Buy
55
ROG
Rogers Corp.
Last Price:
$105.60
Seasonality Move:
3.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-26 | 10Q | ROG/Rogers Corp. Quarterly |
| 2023-10-27 | 10Q | ROG/Rogers Corp. Quarterly |
| 2023-08-04 | 10Q | ROG/Rogers Corp. Quarterly |
| 2023-04-28 | 10Q | ROG/Rogers Corp. Quarterly |
| 2022-11-09 | 10Q | ROG/Rogers Corp. Quarterly |
| 2022-08-05 | 10Q | ROG/Rogers Corp. Quarterly |
Receive ROG News And Ratings
See the #1 stock for the next 7 days that we like better than ROG
ROG Financial Statistics
Sales & Book Value
| Annual Sales: | $810.8M |
|---|---|
| Cash Flow: | $42.2M |
| Price / Cash Flow: | 26.97 |
| Annual Sales: | $67.17 |
| Price / Book: | 1.57 |
Profitability
| EPS (TTM): | -3.34500 |
|---|---|
| Net Income (TTM): | $-61.8M |
| Gross Margin: | $256.8M |
| Return on Equity: | -5.04% |
| Return on Assets: | -4.22% |
Rogers Corp. Earnings Forecast
Key Rogers Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for ROG is 31.67%.
-
The Selling, General & Administrative Expenses for ROG have been equal to 21.78% of Gross Profit Margin.
-
The Research & Development expenses have been 3.47% of Revenue.
-
The Net Earning history of ROG is -7.62% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 22 years.
Rogers Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | ROG |
| CUSIP: | 775133 |
| Website: | rogerscorp.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 3.97 |
| Quick Ratio: | 2.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 73.5 |
|---|---|
| Forward P/E Ratio: | 25.86 |
ROG Technical Analysis vs Fundamental Analysis
Buy
55
Rogers Corp. (ROG)
is a Buy
Is Rogers Corp. a Buy or a Sell?
-
Rogers Corp. stock is rated a BuyThe current Rogers Corp. [ROG] share price is $105.50. The Score for ROG is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.